Angiosarcoma of the scalp presenting in association with borderline malignant phyllodes tumour of the breast

Sarcoma

Volumn 7, Issue 3-4, 2003, Pages 173-176

  Harden, Susan V ^a   Ball, Richard Y ^a   Harnett, Adrian N ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Angiosarcoma; Phyllodes tumour

Indexed keywords

ANTICOAGULANT AGENT; CD31 ANTIGEN; CD34 ANTIGEN; PROTEIN P53;

AGED; ANGIOSARCOMA; ARTICLE; BLEEDING; BREAST; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CYSTOSARCOMA PHYLLOIDES; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EPITHELIUM CELL; FEMALE; HEART ATRIUM FIBRILLATION; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LACERATION; MAMMOGRAPHY; METASTASIS; PRIORITY JOURNAL; SCALP TUMOR; TUMOR BIOPSY;

EID: 0347756667     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13577140310001644823     Document Type: Article

References (14)

1. Salvadori B, Cusumano F, Del Bo R, et al. Surgical treatment of phyllodes tumors of the breast. Cancer 1989; 63: 2532-6.
2. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res 1993; 53: 4071-4.
3. Chaney AW, Pollack A, McNeese MD, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000; 89: 1502-11.
4. Christensen L, Schiodt T, Blichert-Toft M. Sarcomatoid tumours of the breast in Denmark from 1977 to 1987. A clinicopathological and immunohistochemical study of 100 cases. Eur J Cancer 1993; 13: 1824-31.
5. Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996; 77: 910-6.
6. Zissis C, Apostolikas N, Konstantinidou A, Griniatsos J, Vassilopoulos PP. The extent of surgery and prognosis of patients with phyllodes tumor of the breast. Breast Cancer Res Treat 1998; 48: 205-10.
7. Bissett D, Mallon E, Reed NS, George WD, Harnett AN. Cystosarcoma phylloides: heterogeneity in a rare tumour type. J R Coll Surg Edinb 1996; 41: 244-5.
8. Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 1978; 41: 1974-83.
9. Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfversward C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer 1991; 68: 2017-22.
10. Hawkins RE, Schofield JB, Fisher C, Wiltshaw E, McKinna JA. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes. Cancer 1992; 69: 141-7.
11. Birch JM, Alston RD, McNally RJ, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001; 20: 4621-8.
12. Bot FJ, Sleddens HF, Dinjens WN. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma. Diagn Mol Pathol 1998; 7: 295-301.
13. Sasaki R, Soejima T, Kishi K, et al. Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys 2002; 52: 1032-40.
14. Mark RJ, Tran LM, Sercarz J, Fu YS, Calcaterra TC, Juillard GF. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993; 119: 973-8.